Overall study cohort | |||||||||
---|---|---|---|---|---|---|---|---|---|
Readmitted | p Value | ||||||||
(A) All readmitted | (A1) Hypo | (A2) Non-hypo | (B) Not readmitted | (A) vs (B) | |||||
n=1095 | n=158 | n=937 | n=3381 | ||||||
CCI Mean (SD) | 4.2 (2.4) | 3.9 (2.2) | 4.9 (2.5) | 3.3 (2.0) | <0.001 | ||||
n | Per cent | n | Per cent | n | Per cent | n | Per cent | p Value | |
Secondary malignancies | 28 | 2.6 | 0 | 0.0 | 28 | 3.0 | 44 | 1.3 | 0.006 |
Obesity | 175 | 16.0 | 14 | 8.9 | 161 | 17.2 | 438 | 13.0 | 0.013 |
Hypertension | 868 | 79.3 | 132 | 83.5 | 736 | 78.5 | 2343 | 69.3 | <0.001 |
Cardiac dysrhythmias, any | 302 | 27.6 | 37 | 23.4 | 265 | 28.3 | 600 | 17.7 | <0.001 |
Congestive heart failure | 327 | 29.9 | 37 | 23.4 | 290 | 30.9 | 649 | 19.2 | <0.001 |
Cerebrovascular disease | 152 | 13.9 | 19 | 12.0 | 133 | 14.2 | 303 | 9.0 | <0.001 |
COPD and bronchiectasis | 252 | 23.0 | 33 | 20.9 | 219 | 23.4 | 453 | 13.4 | <0.001 |
Chronic renal failure | 461 | 42.1 | 62 | 39.2 | 399 | 42.6 | 999 | 29.5 | <0.001 |
Mood disorders | 273 | 24.9 | 39 | 24.7 | 234 | 25.0 | 513 | 15.2 | <0.001 |
Substance-related disorders | 119 | 10.9 | 13 | 8.2 | 106 | 11.3 | 175 | 5.2 | <0.001 |
CCI, Charlson Comorbidity Index; COPD, chronic obstructive pulmonary disease.